The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: a Systematic Review
A number of novel medications, which have not been approved by the FDA to treat autism spectrum disorder (ASD) have been used off-label in some studies to treat ASD symptoms, including medications approved for Alzheimer’s disease. Interestingly, some of these studies are high-quality, double-blind, placebo-controlled (DBPC) studies. This article systematically reviews studies published through April, 2014, which examined the use of Alzheimer’s medications in ASD and their impact.